New Funding Challenges
For several years, Winship Cancer Institute of Emory University has been working to keep its cancer research and clinical trials programs going despite federal budget cuts. Continue Reading>>
Winship Newsroom | Hematology/Medical Oncology News
Dr. Fadlo R Khuri, MD, is Professor & Chair, Department of Hematology & Medical Oncology, Emory School of Medicine. Dr. Khuri's research and clinical interests focus on the development of novel therapeutic and prevention approaches for lung and aerodigestive cancers. In 2014, Dr. Khuri was elected as a Fellow to the American Association for the Advancement of Science (AAAS). Dr. Khuri draws on his career-long commitment to evidence-based, biologically informed medicine to develop molecularly targeted therapy for lung and aerodigestive cancer prevention and treatment.